Quick Summary
Pomalid 4mg Capsule
Last updated on 26 Sep 2026 | 08:44 AM (IST)
ā¹7575
MRP: ā¹14949.6
(You Save ā¹7374.6)
21 CAPSULE(s) IN A STRIP
49% OFF
ā¹7575
MRP: ā¹14,949.60
Inclusive of all taxes
49% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Pomabuzz 4mg Capsule
JASGUR LIFE SCI...
ā¹ 248.05/capsule
31% cheaper
Bdpoma 4mg Capsule
BDR PHARMACEUTI...
ā¹ 255.81/capsule
29% cheaper
Pomcad 4mg Capsule
CADILA PHARMACE...
ā¹ 288.43/capsule
20% cheaper
Pomide 4mg Capsule
HETERO HEALTHCA...
ā¹ 305.19/capsule
15% cheaper
Introduction to Pomalid 4mg Capsule
Pomalid 4mg Capsule is a chemotherapy medicine containing the active constituent Pomalidomide. It belongs to the group of medications known as Immuno modulatory agents. It is used to treat multiple myeloma in adults. Multiple myeloma is a type of cancer mainly affecting certain white blood cells called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys. Ā
The common side effects that are likely to associate with PomalidĀ 4mg CapsuleĀ are shortness of breath, tiredness, weakness, nausea, vomiting, diarrhea, constipation, back and bone pain, dizziness, tremor, upper respiratory tract infection, sleeping trouble, loss of appetite, lack of energy, muscle spasms, muscle weakness, numbness, tingling or burning sensation, the low potassium level in the blood and anemia. Inform your doctor if these side effects disturb or persist in you. Ā
Inform your medical professional if you are allergic to PomalidĀ 4mg CapsuleĀ and its ingredients. Inform your doctor if you have high cholesterol levels, heart disorders, breathing problems, blood clot disorders, hepatitis B infection, neuropathy (Pain in hands or feet caused by nerve damage), or if you smoke before taking this chemotherapy medicine. It is not recommended for adolescents and children under 18 years of age.Ā
Uses of Pomalid 4mg Capsule
- Treatment of Multiple myeloma.
Therapeutic Effects of Pomalid 4mg Capsule
PomalidĀ 4mg CapsuleĀ works by stimulating the immune system to attack the cancer cells, stopping the formation of blood vessels supplying the cancer cells, and preventing the growth of cancer cells (myeloma cells).
Interaction of Pomalid 4mg Capsule with other drugs
Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medications may interact with PomalidĀ 4mg CapsuleĀ and can cause potential side effects.
More Information about Pomalid 4mg Capsule
- Keep PomalidĀ 4mg CapsuleĀ out of sight and reach of children.
- Store at room temperature between 20Ā°C to 25Ā°C.
How to consume Pomalid 4mg Capsule
Always take PomalidĀ 4mg CapsuleĀ exactly as prescribed by your doctor. Take this medicine with or without food. Swallow the CapsuleĀ as a whole with water. Do not crush or chew the Capsule.
Safety Advice for Pomalid 4mg Capsule
Breast Feeding
It is not recommended to use during breastfeeding as it is unknown if PomalidĀ 4mg CapsuleĀ passes into breast milk and harms the baby.
Alcohol
It is not known whether it is safe to consume alcohol with PomalidĀ 4mg Capsule. Please consult your doctor.
Liver
PomalidĀ 4mg CapsuleĀ is used with caution in severe liver disease patients. A dose adjustment is required. Your physician will perform blood tests to monitor your liver function during treatment with this medication.
Lungs
It is unknown whether PomalidĀ 4mg CapsuleĀ can be given to patients with lung disorders. Consult your doctor if you have any lung problems before starting the treatment.Ā
Driving
Do not drive or operate heavy machines while taking PomalidĀ 4mg Capsule, as it can cause tiredness, dizziness, and confusion.Ā
Pregnancy
PomalidĀ 4mg CapsuleĀ is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine.
Side Effects of Pomalid 4mg Capsule
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Ā
Serious:
- Low white blood cells
- Bleeding or bruising
- Severe or bloody diarrhea
- Blood clots (chest or leg pain, swelling)
- Severe liver problems (yellowing of skin or eyes, dark-brow color urine, abdominal Pain)
- Severe allergic reactions (swelling of face, lips, tongue, or throat, difficulty breathing)
Common:
- Shortness of breath
- Tiredness, weakness
- Nausea, vomiting
- Dizziness, tremor
- Low potassium level in the blood (hypokalaemia)
- Back pain, bone pain
- Diarrhea, constipation
- Upper respiratory tract infection
- High blood sugar levels
- Loss of appetite, lack of energy
- Trouble sleeping
- Muscle spasms, muscle weakness
- Numbness, tingling, or burning sensation in the skin, Pain in hands or feet
- Anemia
Word of Advice
It is recommended to take effective birth control for at least 4 weeks before beginning treatment, during treatment, and at least 4 weeks after stopping PomalidĀ 4mg CapsuleĀ treatment. Women who are pregnant or suspect they may be pregnant should not use this medication. Handle this medication with disposable gloves since it may come into contact with the skin. Do not share PomalidĀ 4mg CapsuleĀ with others even if they have the same symptoms as you have, since it may cause birth defects and other serious problems. It is advised to refrain from donating blood or sperm both during treatment and for seven days after treatment with this drug.
FAQs about Pomalid 4mg Capsule
Q1.
What class of medication is PomalidĀ 4mg Capsule?
PomalidĀ 4mg CapsuleĀ belongs to the class of medications called Immuno modulatory agents.
Q2.
What is the best time to take PomalidĀ 4mg Capsule?Ā
It is best to take PomalidĀ 4mg CapsuleĀ once daily, with or without food. Take the capsule at the same time every day for better results.
Q3.
I am suffering from a Hepatitis B virus infection. Can I take PomalidĀ 4mg Capsule?
PomalidĀ 4mg CapsuleĀ should not be used in patients with hepatitis B virus infection. PomalidĀ 4mg CapsuleĀ treatment may reactivate the hepatitis B virus in people who have the virus, resulting in a recurrence of the infection.
Q4.
Can children use PomalidĀ 4mg Capsule?
No, PomalidĀ 4mg CapsuleĀ is not recommended for usage in children under 18.Ā
Q5.
Can I donate blood during PomalidĀ 4mg CapsuleĀ treatment?
Blood donations are restricted while taking PomalidĀ 4mg CapsuleĀ and for one month after stopping the medicine because the blood might be given to pregnant women whose fetuses should not be exposed to this medication.
Q6.
In which conditions should I avoid taking PomalidĀ 4mg Capsule?Ā
PomalidĀ 4mg CapsuleĀ should not be used in patients with blood clots, heart attack, heart failure, breathing difficulty, high blood pressure and cholesterol levels, neuropathy, and hepatitis B virus infection.
Q7.
Can I share PomalidĀ 4mg CapsuleĀ with other people?
No, sharing PomalidĀ 4mg CapsuleĀ medication with others is not recommended, even if they have the same symptoms as you. Hence, it may cause birth defects and other problems.
Q8.
What should I do if I miss my PomalidĀ 4mg CapsuleĀ dose?
Take your missed PomalidĀ 4mg CapsuleĀ dose as soon as you remember if it has been less than 12 hours since your usual time. Skip the dose you missed if it has been more than 12 hours. Do not take two doses at the same time.
Fact Box of Pomalid 4mg Capsule
Molecule name: Pomalidomide | Therapeutic class: Immunomodulatory agents |
Pharmacological class: Antineoplastics | Indications: Multiple myeloma |
References
1.Bristol-Myers Squibb Pharma EEIG, Electronic medicines compendium (EMC), [ Revised on Feb 2022] [ Accessed on 28 Nov 2022], https://www.medicines.org.uk/emc/files/pil.1262.pdfĀ
2.Celgene corporation, US Food and Drug Administration, [ Revised on Dec 2017] [ Accessed on 28 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204026s019lbl.pdfĀ
3.Rafael Rios-Tamayo et al; Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy; Drug Design, Development and Therapy; Published on 28/08/2017; Accessed on 28/09/2022; https://www.ncbi.nlm.nih.gov/pubmed/28860711
Disclaimer
MrMedās primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:44 AM (IST)
Want to know more?
Read Our Editorial Policy
